Abstract
Purpose
Linear tumor size (T-size) estimated with conventional histology informs breast cancer management. Previously we demonstrated significant differences in margin and focality estimates using conventional histology versus digital whole-mount serial sections (WMSS). Using WMSS we can measure T-size or volume. Here, we compare WMSS T-size with volume, and with T-size measured conventionally. We also compare the ellipsoid model for calculating tumor volume to direct, WMSS measurement.
Methods
Two pathologists contoured regions of invasive carcinoma and measured T-size from both WMSS and (simulated) conventional sections in 55 consecutive lumpectomy specimens. Volume was measured directly from the contours. Measurements were compared using the paired t-test or Spearman’s rank-order correlation. A five-point ‘border index’ was devised and assigned to each case to parametrize tumor shape considering ‘compactness’ or cellularity. Tumor volumes calculated assuming ellipsoid geometry were compared with direct, WMSS measurements.
Results
WMSS reported significantly larger T-size than conventional histology in the majority of cases [61.8%, 34/55; means = (2.34 cm; 1.99 cm), p < 0.001], with a 16.4% (9/55) rate of ‘upstaging’. The majority of discordances were due to undersampling. T-size and volume were strongly correlated (r = 0.838, p < 0.001). Significantly lower volume was obtained with WMSS versus ellipsoid modeling [means = (1.18 cm3; 1.45 cm3), p < 0.001].
Conclusions
Significantly larger T-size is measured with WMSS than conventionally, due primarily to undersampling in the latter. Volume and linear size are highly correlated. Diffuse tumors interspersed with normal or non-invasive elements may be sampled less extensively than more localized masses. The ellipsoid model overestimates tumor volume.
Similar content being viewed by others
Data Availability
The datasets created and analyzed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- TNM:
-
Tumor Node Metastasis
- AJCC/UICC:
-
American Joint Committee on Cancer/Union for International Cancer Control
- 3-D:
-
Three-dimensional
- WMSS:
-
Whole-mount serial sections
- WM:
-
Whole-mount
- H&E:
-
Hematoxylin and eosin
- SCS:
-
Simulated conventional sections
- AP:
-
Anterior–posterior
- SI:
-
Superior–inferior
- ML:
-
Medial–lateral
- BI:
-
Border Index
References
Fisher B, Slack NH, Bross ID (1969) Cancer of the breast: size of neoplasm and prognosis. Cancer 24:1071–1080
Tabar L, Vitak B, Chen HH et al (2000) The Swedish Two-County Trial twenty years later. updated mortality results and new insights from long-term follow-up. Radiol Clin N Am 38:625–651
Leitner SP, Swern AS, Weinberger D et al (1995) Predictors of recurrence for patients with small (one centimeter or less) localized breast cancer (T1a,b N0 M0). Cancer 76:2266–2274
Koscielny S, Tubiana M, Le MG et al (1984) Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer 49:709–715
Amin M, Edge S, Greene F et al (2017) AJCC cancer staging manual, 8th edn. Springer, Chicago
Carter CL, Allen C, Henson DE (1989) Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63:181–187
Koscielny S, Tubiana M, Lê MG et al (1984) Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer 49:709–715
Smart CR, Myers MH, Gloeckler LA (1978) Implications from SEER data on breast cancer management. Cancer 41:787–789
Lester S, Bose S, Chen Y-Y et al (2013) Protocol for the examination of specimens from patients with invasive carcinoma of the breast protocol applies to all invasive carcinomas of the breast, including ductal. Arch Pathol Lab Med 133(10):1515–1538
Graham R, Homer MJ, Katz J et al (2002) The pancake phenomenon contributes to the inaccuracy of margin assessment in patients with breast cancer. Am J Surg 184:89–93
Clarke GM, Holloway CMB, Zubovits JT et al (2016) Whole-mount pathology of breast lumpectomy specimens improves detection of tumour margins and focality. Histopathology 69:35–44. https://doi.org/10.1111/his.12912
Michaelson JS, Silverstein M, Wyatt J et al (2002) Predicting the survival of patients with breast carcinoma using tumor size. Cancer 95:713–723. https://doi.org/10.1002/cncr.10742
Hofmeyer S, Pekár G, Gere M et al (2012) Comparison of the subgross distribution of the lesions in invasive ductal and lobular carcinomas of the breast: a large-format histology study. Int J Breast Cancer 2012:436141. https://doi.org/10.1155/2012/436141
Dekker TJA, van de Velde CJH, van Pelt GW et al (2013) Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854). Breast Cancer Res Treat 139:371–379. https://doi.org/10.1007/s10549-013-2571-5
Downey CL, Simpkins SA, White J et al (2014) The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer. Br J Cancer 110:1744–1747. https://doi.org/10.1038/bjc.2014.69
Moorman AM, Vink R, Heijmans HJ et al (2012) The prognostic value of tumour-stroma ratio in triple-negative breast cancer. Eur J Surg Oncol 38:307–313. https://doi.org/10.1016/j.ejso.2012.01.002
Guth U, Brenckle D, Huang DJ et al (2009) Three-dimensional pathological size assessment in primary breast carcinoma. Breast Cancer Res Treat 116:257–262
Kerr KM, Lamb D (1988) A comparison of patient survival and tumour growth kinetics in human bronchogenic carcinoma. Br J Cancer 58:419–422
Tsai CH, Lin CM, Hsieh CC et al (2006) Tumor volume is a better prognostic factor than greatest tumor diameter in stage Ia non-small cell lung cancer. Thorac Cardiovasc Surg 54:537–543
Mai KT, Mokhtar G, Burns BF et al (2003) A simple technique for calculation of the volume of prostatic adenocarcinomas in radical prostatectomy specimens. Pathol Res Pr 199:599–604
Clarke GM, Murray M, Holloway CMB et al (2012) 3D pathology volumetric technique: a method for calculating breast tumour volume from whole-mount serial section images. Int J Breast Cancer 2012:691205. https://doi.org/10.1155/2012/691205
Sun L, Wang D, Zubovits JT et al (2009) An improved processing method for breast whole-mount serial sections for three-dimensional histopathology imaging. Am J Clin Pathol 131:383–392. https://doi.org/10.1309/AJCPVBZZ4IKJHY3U
Clarke GM, Eidt S, Sun L et al (2007) Whole-specimen histopathology: a method to produce whole-mount breast serial sections for 3-D digital histopathology imaging. Histopathology 50:232–242. https://doi.org/10.1111/j.1365-2559.2006.02561.x
Clarke GM, Peressotti C, Constantinou P et al (2010) Increasing specimen coverage using digital whole-mount breast pathology: implementation, clinical feasibility and application in research. Comput Med Imaging Graph 35:531–541. https://doi.org/10.1016/j.compmedimag.2011.05.002
Clarke GM, Zubovits JT, Katic M et al (2007) Spatial resolution requirements for acquisition of the virtual screening slide for digital whole-specimen breast histopathology. Hum Pathol 38:1764–1771. https://doi.org/10.1016/j.humpath.2007.04.006
Wapnir IL, Wartenberg DE, Greco RS (1996) Three dimensional staging of breast cancer. Breast Cancer Res Treat 41:15–19
Merrill AL, Buckley J, Tang R et al (2016) A study of the growth patterns of breast carcinoma using 3D reconstruction: a pilot study. Breast J. https://doi.org/10.1111/tbj.12688
Moon HG, Kim N, Jeong S et al (2015) The clinical significance and molecular features of the spatial tumor shapes in breast cancers. PLoS ONE 10:1–14. https://doi.org/10.1371/journal.pone.0143811
Jackson PA, Merchant W, McCormick CJ, Cook MG (1994) A comparison of large block macrosectioning and conventional techniques in breast pathology. Virchows Arch 425:243–248
Foschini MP, Baldovini C, Ishikawa Y, Eusebi V (2012) The value of large sections in surgical pathology. Int J Breast Cancer 2012:785947. https://doi.org/10.1155/2012/785947
Foster MR, Harris L, Biesemier KW (2012) Large format histology may aid in the detection of unsuspected pathologic findings of potential clinical significance: a prospective multiyear single institution study. Int J Breast Cancer 2012:532547. https://doi.org/10.1155/2012/532547
Tot T (2003) The diffuse type of invasive lobular carcinoma of the breast: morphology and prognosis. Virchows Arch 443:718–724. https://doi.org/10.1007/s00428-003-0881-4
Tot T (2007) Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections. Cancer 110:2551–2560. https://doi.org/10.1002/cncr.23052
Tot T (2016) Diffuse invasive breast carcinoma of no special type. Virchows Arch 468:199–206. https://doi.org/10.1007/s00428-015-1873-x
Güth U, Brenckle D, Huang DJ et al (2009) Three-dimensional pathological size assessment in primary breast carcinoma. Breast Cancer Res Treat 116:257–262. https://doi.org/10.1007/s10549-008-0115-1
Acknowledgements
The authors are grateful to Ms Anoma Gunasekara for her assistance with recruitment, and together with Ms Yulia Yerofeyeva with organizing all aspects of the study logistics and patient tracking. Finally we acknowledge the co-operation of pathologist assistants Ms Anna-Marie Moskaluk, Mr Ian Cooper. Dr Laibao Sun and Dr Peter Leventis for performing the virtual sampling and overseeing the research protocol, and Adebayo Adeeko for assistance with specimen preparation.
Funding
This work was supported by the Canadian Breast Cancer Research Alliance/Canadian Cancer Society Research Institute.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors do not have a conflict of interest.
Ethical approval
This study was conducted in full compliance with the applicable, current Canadian law.
Rights and permissions
About this article
Cite this article
Clarke, G.M., Holloway, C.M.B., Zubovits, J.T. et al. Three-dimensional tumor visualization of invasive breast carcinomas using whole-mount serial section histopathology: implications for tumor size assessment. Breast Cancer Res Treat 174, 669–677 (2019). https://doi.org/10.1007/s10549-018-05122-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-018-05122-7